Epigenetic Modulation of Inflammatory Pathways in Myometrial Stem Cells and Risk of Uterine Fibroids
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241411641 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Qiwei Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Leiomyoma, Uterine Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
The period during which tissue and organ development occurs is particularly vulnerable to the influence of environmental exposures. However, the specific mechanisms through which biological pathways are disrupted in response to developmental insults, consequently elevating the risk of hormone-dependent diseases, such as uterine fibroids (UFs), remain poorly understood. Here, we show that developmental exposure to the endocrine-disrupting chemical (EDC), diethylstilbestrol (DES), activates the inflammatory pathways in myometrial stem cells (MMSCs), which are the origin of UFs. Significantly, the secretome of reprogrammed MMSCs enhances the expression of critical inflammation-related genes in differentiated myometrial cells through the paracrine mechanism, which amplifies pro-inflammatory and immune suppression signaling in the myometrium. The expression of reprogrammed inflammatory responsive genes (IRGs) is driven by activated mixed-lineage leukemia protein-1 (MLL1) in MMSCs. The deactivation of MLL reverses the reprogramming of IRG expression. In addition, the inhibition of histone deacetylases (HDACs) also reversed the reprogrammed IRG expression induced by EDC exposure. This work identifies the epigenetic mechanisms of MLL1/HDAC-mediated MMSC reprogramming, and EDC exposure epigenetically targets MMSCs and imparts an IRG expression pattern, which may result in a “hyper-inflammatory phenotype” and an increased hormone-dependent risk of UFs later in life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.
- Division of Health Equities, Department of Population Sciences, City of Hope, Duarte, CA 91010, USA.
- INCLIVA Health Research Institute Avda, Menéndez Pelayo 4, 46010 Valencia, Spain.
- Department of Pathology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
ORCID-Profile: Qiwei Yang, Mohamed Ali, Aymara Mas, Ayman Al-Hendy
Förderung
- NIEHS NIH HHS
- NIH HHS
- NICHD NIH HHS
- NIMHD NIH HHS
- Augusta University Intramural Grants Program
- CPRIT Core Facility Support
- NIEHS Grant
- Miguel Servet Spanish Program Grant
Zitieren
APA
Yang, Q., Ali, M., Treviño, L. S., Mas, A., Ismail, N., & Al-Hendy, A. (2023). Epigenetic Modulation of Inflammatory Pathways in Myometrial Stem Cells and Risk of Uterine Fibroids. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411641
Vancouver
Yang Q, Ali M, Treviño LS, Mas A, Ismail N, Al-Hendy A. Epigenetic Modulation of Inflammatory Pathways in Myometrial Stem Cells and Risk of Uterine Fibroids. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411641
BibTeX
@article{Yang2023,
author = {Yang, Qiwei and Ali, Mohamed and Treviño, Lindsey S and Mas, Aymara and Ismail, Nahed and Al-Hendy, Ayman},
title = {Epigenetic Modulation of Inflammatory Pathways in Myometrial Stem Cells and Risk of Uterine Fibroids},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241411641}
}
EUVIMED